In order to identify molecular models of the human 5-HT6 receptor suitable for virtual screening, homology modeling and membrane-embedded molecular dynamics simulations were performed. Structural requirements for robust enrichment were assessed by an unbiased chemometric analysis of enrichments from retrospective virtual screening studies. The two main structural features affecting enrichment are the outward movement of the second extracellular loop and the formation of a hydrophobic cavity deep in the binding site. These features appear transiently in the trajectories and furthermore the stretches of uniformly high enrichment may only last 4-10 ps. The formation of the inner hydrophobic cavity was also linked to the active-like to inactive...
Virtual screening towards the search of new 5-HT6R ligands was carried out with three different fing...
The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that regulates the ex...
On the basis of a set of 20 diverse 5-HT7 receptor agonists, the pharmacophore for 5-HT7 receptor ag...
5-HT6 receptor has been implicated in a series of diseases including anxiety, depression, schizophre...
<p>The subtype, 5-HT<sub>7</sub>R has been implicated in neurological disorders and presents itself ...
The pharmacologically characterized receptor subtype of the serotonin family, the 5HT1A receptor is ...
Abstract A new pharmacophore-based modeling procedure, including homology modeling, pharmacophore st...
Comparative molecular dynamics simulations of the 5-HT1A receptor in its empty as well as agonist(i....
In Chapter 1 a review of the 5-HT1B receptor is conducted, describing physiological and pathological...
The 5-hydroxytryptamine receptor 6 (5-HT6) has gained attention as a target for developing therapeut...
In this work, we evaluate the structural differences of trans-membrane helix 3 in rhodopsin and the ...
<div><p>From computational simulations of a serotonin 2A receptor (5-HT<sub>2A</sub>R) model complex...
HT1D receptor subtypes suggest that a threonine in the seventh mechanism. The hydrogen bond between ...
thesisThe implications of receptor dynamics virtual screening were explored as part of proof of conc...
5-HT(1A) serotonin and D1 dopamine receptor agonists have been postulated to be able to improve nega...
Virtual screening towards the search of new 5-HT6R ligands was carried out with three different fing...
The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that regulates the ex...
On the basis of a set of 20 diverse 5-HT7 receptor agonists, the pharmacophore for 5-HT7 receptor ag...
5-HT6 receptor has been implicated in a series of diseases including anxiety, depression, schizophre...
<p>The subtype, 5-HT<sub>7</sub>R has been implicated in neurological disorders and presents itself ...
The pharmacologically characterized receptor subtype of the serotonin family, the 5HT1A receptor is ...
Abstract A new pharmacophore-based modeling procedure, including homology modeling, pharmacophore st...
Comparative molecular dynamics simulations of the 5-HT1A receptor in its empty as well as agonist(i....
In Chapter 1 a review of the 5-HT1B receptor is conducted, describing physiological and pathological...
The 5-hydroxytryptamine receptor 6 (5-HT6) has gained attention as a target for developing therapeut...
In this work, we evaluate the structural differences of trans-membrane helix 3 in rhodopsin and the ...
<div><p>From computational simulations of a serotonin 2A receptor (5-HT<sub>2A</sub>R) model complex...
HT1D receptor subtypes suggest that a threonine in the seventh mechanism. The hydrogen bond between ...
thesisThe implications of receptor dynamics virtual screening were explored as part of proof of conc...
5-HT(1A) serotonin and D1 dopamine receptor agonists have been postulated to be able to improve nega...
Virtual screening towards the search of new 5-HT6R ligands was carried out with three different fing...
The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that regulates the ex...
On the basis of a set of 20 diverse 5-HT7 receptor agonists, the pharmacophore for 5-HT7 receptor ag...